Pengarang: Admin, AsiaFitnessToday

HANGZHOU, China, Feb. 14, 2019 /PRNewswire/ — China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other…

-Imposes Damages & Orders Halt to Manufacturing and Sales PARIS, Feb. 14, 2019 /PRNewswire/ — Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of…

BANGKOK, Feb. 14, 2019 /PRNewswire/ — Thailand has been experiencing a gradual shift from a manufacturing to a high-value manufacturing economy after the country has put all its efforts into…

In Clinical Trials, Biktarvy Demonstrated High Efficacy and Zero Resistance Through 48 Weeks SINGAPORE, Feb. 14, 2019 /PRNewswire/ — Gilead Sciences, Inc. today announced that the Singapore Health Sciences Authority…

Arvelle Therapeutics to receive rights to develop and commercialize cenobamate, an investigational antiepileptic drug developed by SK Biopharmaceuticals, in Europe SK Biopharmaceuticals to receive upfront payment of $100 million and…

SINGAPORE, Feb. 13, 2019 /PRNewswire/ — Novartis is on a mission to transform healthcare in Asia by partnering with the health tech ecosystem. Alexis Serlin, Head of Asia Cluster, Novartis…

Delivers Continued Momentum in 2018 Through Broadly-based Sales Growth YONGIN, South Korea, Feb. 12, 2019 /PRNewswire/ — GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean…

SEONGNAM, South Korea, Feb. 11, 2019 /PRNewswire/ — Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company presented the preclinical and the…

SHENYANG, China and BOSTON, Feb. 11, 2019 /PRNewswire/ — 3SBio Inc. (“3SBio”) (HKEX:1530) and Verseau Therapeutics, Inc. (“Verseau”) announced today a partnership agreement focused on the development and commercialization of…